BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 29

• Business

  Starpharma Holdings Ltd Release: National Institutes of Health (NIH) Funds Clinical Development Of VivaGel(TM) For Genital Herpes

  April 20, 2006

   · 

  4 min read
• Deals

  Mission Pharmacal Company Acquires Tindamax(R): Treatment For Trichomoniasis, Most Common Non-Viral Sexually Transmitted Disease

  April 20, 2006

   · 

  3 min read
• Japan The Science And Technology Foundation Of U.K. Release: Japanese Scientists Receive Japan Prize On April 20

  April 20, 2006

   · 

  1 min read
• Biotech Bay

  ZONARE Medical Systems, Inc. And Epic Brand Communications Capture Best Of Show At DxMA Awards

  April 20, 2006

   · 

  3 min read
• Pharm Country

  Strategic Research Institute Release: Targeting Ubiquitin For Drug Discovery And Development Conference To Explore State-Of-The-Art Science For New Therapeutic Drug Applications

  April 20, 2006

   · 

  1 min read
• Policy

  Novartis Pharmaceuticals Corporation Release: New Drug Application (NDA) For Rasilez(R) (Aliskiren), An Innovative Oral Renin Inhibitor To Treat High Blood Pressure, Accepted For Review By The US FDA

  April 20, 2006

   · 

  5 min read
• Policy

  Federman & Sherwood Announces That A Class Action Lawsuit Has Been Filed Against Bausch & Lomb

  April 20, 2006

   · 

  1 min read
• BioMidwest

  St. Paul Heart Clinic Seeks Heart Failure Patients For Investigational Study Evaluating Use Of New Implantable Pulse Generator

  April 20, 2006

   · 

  2 min read
• Business

  Acuity Pharmaceuticals Continues Pipeline Expansion By Licensing A Novel Broad Spectrum Anti-Infective For Ophthalmic Use

  April 20, 2006

   · 

  4 min read
• Biotech Beach

  Halozyme Therapeutics, Inc. Receives Approximately $1.9 Million From Exercise Of Warrants

  April 20, 2006

   · 

  2 min read